JNJ
Johnson & JohnsonNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$549.78B
P/E Ratio
26.46
EPS
$8.63
Beta
0.26
52W High
$250.24
52W Low
$146.07
50-Day MA
$230.37
200-Day MA
$215.73
Dividend Yield
2.22%
Profit Margin
21.80%
Forward P/E
19.72
PEG Ratio
2.97
About Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Fundamentals
| Revenue (TTM) | $96.36B |
| Gross Profit (TTM) | $65.56B |
| EBITDA | $34.33B |
| Operating Margin | 27.40% |
| Return on Equity | 26.40% |
| Return on Assets | 8.42% |
| Revenue/Share (TTM) | $40.02 |
| Book Value | $33.73 |
| Price-to-Book | 6.77 |
| Price-to-Sales (TTM) | 5.71 |
| EV/Revenue | 6.05 |
| EV/EBITDA | 17.28 |
| Quarterly Earnings Growth (YoY) | -52.90% |
| Quarterly Revenue Growth (YoY) | 9.90% |
| Shares Outstanding | $2.41B |
| Float | $2.40B |
| % Insiders | 0.05% |
| % Institutions | 76.85% |
Historical Volatility
HV 10-Day
24.33%
HV 20-Day
22.01%
HV 30-Day
21.04%
HV 60-Day
19.03%
HV Rank
88.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($252.87 target)
5
Strong Buy10
Buy8
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/19/2026